You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 72 No. 2, August 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (65)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Aminopterin for Psoriasis

REES B. REES, M.D.; JAMES H. BENNETT, M.D.; WARREN L. BOSTICK, M.D.

AMA Arch Derm. 1955;72(2):133-143.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Aminopterin (4-a m i n o-pteroylglutamic acid) is a potentially dangerous drug. It can favorably affect the lesions of psoriasis regularly, but the range between beneficial and toxic doses is narrow. The possibility of irreversible bone marrow aplasia is of chief concern in toxicity. Gubner1 has shown, however, that administration of the drug in conservative doses to nonleukemic individuals does not provoke such a disastrous complication. He has made the following observations: significant changes in psoriatic lesions were observed regularly in all patients (a total of 13, of whom 7 had associated arthritis) who were given Aminopterin. The dosage was 1.5 to 2.0 mg. daily, the total dose varying in individual cases from 14 to 140 mg. in from 10 days to nine months. Scaling stopped between the 5th and 10th days. Several patients had hemorrhagic crusting in the lesions at the time of improve . . . [Full Text PDF of this Article]


Author Affiliations

San Francisco

From the Subdepartment of Dermatology (Drs. Rees and Bennett) and the Department of Pathology (Dr. Bostick), University of California School of Medicine.


Footnotes

Submitted for publication May 23, 1955.

Read before the 75th Annual Meeting of the American Dermatological Association, Inc., Belleair, Fla., April 18, 1955.

Case reports and assistance were contributed by the following physicians: Norman N. Epstein, Michael Franzblau, Werner Gugelman, Edwin M. Hamlin, Jonah Li, Bernard Rhodes, and Wayne Wright.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.